MedicineWorld.Org
Your gateway to the world of medicine
Home
News
Cancer News
About Us
Cancer
Health Professionals
Patients and public
Contact Us
Disclaimer

Medicineworld.org: Avastin And Taxol For Breast Cancer

Back to breast cancer blog Blogs list Cancer blog  


Subscribe To Breast Cancer Blog RSS Feed  RSS content feed What is RSS feed?

Avastin And Taxol For Breast Cancer

Avastin And Taxol For Breast Cancer
Avastin, and anti-angiogenesis drug is now showing promise in the treatment of patients with metastatic breast cancer. A new research led by Dr Robin Zon, of Michiana Hematology-Oncology, PC in South Bend, Indiana has shown that combining Avastin with Taxol improves outcome in patients with metastatic breast cancer. The study has shown that a combination of Avastin and Taxol is more effective in prevention of progression of breast cancer compared to using Taxol alone.

Avastin is an anti-angiogenesis drug that works by blocking the formation of new blood vessels by the growing cancer cells. Some claim that the combination of chemotherapy and Avastin works better by facilitating chemotherapy delivery to the cancer cells.

This new research studied effectiveness of Avastin in combination with Taxol. The study enrolled in total of 722 patients with advanced breast cancer. The study found that combination of Avastin and Taxol was capable of keeping the cancer stable for a period of 11.4 months in women who received the drug combo compared to 6.11 months in patients who had only been given Taxol.

Researchers say that this presents yet another option for patients with advanced breast cancer. "These results are good news for people with breast cancer," said Zon who presented the results of the trial sponsored by the U.S. National Cancer Institute at the 5th European Breast Cancer Conference in Nice, France.

Researchers are planning to take this finding to the next step. They are planning to test the combination of Avastin and Taxol for prevention of breast cancer recurrence in patients with early stage breast cancer.

Avastin is currently FDA approved for the treatment of metastatic colorectal cancer and advanced lung cancer, and has been shown to improve survival in the setting.




Did you know?
Avastin, and anti-angiogenesis drug is now showing promise in the treatment of patients with metastatic breast cancer. A new research led by Dr Robin Zon, of Michiana Hematology-Oncology, PC in South Bend, Indiana has shown that combining Avastin with Taxol improves outcome in patients with metastatic breast cancer. The study has shown that a combination of Avastin and Taxol is more effective in prevention of progression of breast cancer compared to using Taxol alone.

Medicineworld.org: Avastin And Taxol For Breast Cancer

BREAST CANCER MAIN| Home| Breast cancer news| Common terms| Breast cancer treatment| Breast cancer treatment by stage| Mammogram and breast cancer screening| Surgical treatment of breast cancer| Chemotherapy of breast cancer| Chemo drugs used in breast cancer| Doxorubicin| Cyclophosphamide| Methotrexate| Hormonal therapy of breast cancer| Radiation therapy of breast cancer| Monoclonal therapy| High dose chemotherapy for breast cancer| Recurrent breast cancer| Bisphosphonates and breast cancer| Pregnancy and breast cancer| Risk factors for breast cancer| Risk details| My risk| Comprehensive breast cancer information| Breast cancer statistics| African Americans and breast cancer| Ashkenazi and breast cancer| Asians| Hispanic| Men| Native Americans| Older women and breast cancer| Younger women| Pregnant women and breast cancer| BRCA|

Copyright statement
The contents of this web page are protected. Legal action may follow for reproduction of materials without permission.